RemSleep Holdings, Inc. is a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients. Our focus is primarily designing and manufacturing devices and products for the treatment of Sleep Apnea and other respiratory conditions. With over 30 years of collective experience in CPAP therapy, the RemSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. We diligently strive for our products to make the difference and improve the condition of those suffering from Sleep Apnea.
Company profile
Ticker
RMSL
Exchange
Website
CEO
Tom Wood
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Bella Viaggio, Inc., Kat Gold Holdings Corp., OBICOM, INC.
SEC CIK
Corporate docs
IRS number
383759675
RMSL stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
16 Apr 24
NT 10-K
Notice of late annual filing
29 Mar 24
UPLOAD
Letter from SEC
29 Feb 24
424B3
Prospectus supplement
14 Feb 24
EFFECT
Notice of effectiveness
14 Feb 24
CORRESP
Correspondence with SEC
12 Feb 24
S-1
IPO registration
2 Feb 24
8-K
Entry into a Material Definitive Agreement
18 Dec 23
10-Q
2023 Q3
Quarterly report
15 Nov 23
NT 10-Q
Notice of late quarterly filing
15 Nov 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 904.36 k | 904.36 k | 904.36 k | 904.36 k | 904.36 k | 904.36 k |
Cash burn (monthly) | 59.30 k | 104.72 k | 90.44 k | 94.88 k | 56.80 k | 74.09 k |
Cash used (since last report) | 412.01 k | 727.55 k | 628.38 k | 659.24 k | 394.62 k | 514.79 k |
Cash remaining | 492.36 k | 176.81 k | 275.98 k | 245.12 k | 509.74 k | 389.57 k |
Runway (months of cash) | 8.3 | 1.7 | 3.1 | 2.6 | 9.0 | 5.3 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|